503 3MG Pill - green round, 8mm
Generic Name: guanfacine
Pill with imprint 503 3MG is Green, Round and has been identified as Intuniv 3 mg. It is supplied by Shire US Inc.
Intuniv is used in the treatment of ADHD and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Intuniv 3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 503 3MG
Intuniv
- Generic Name
- guanfacine
- Imprint
- 503 3MG
- Strength
- 3 mg
- Color
- Green
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, centrally acting
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Shire US Inc.
- National Drug Code (NDC)
- 54092-0517
- Inactive Ingredients
-
hypromellose 2208 (15000 mPa.s),
lactose monohydrate,
methacrylic acid - methyl methacrylate copolymer (1:1),
microcrystalline cellulose,
glyceryl dibehenate,
fumaric acid
Note: Inactive ingredients may vary.
See also:
Adderall
Adderall (amphetamine and dextroamphetamine) is used to treat narcolepsy and ADHD. Includes side ...
Vyvanse
Vyvanse is a prescription stimulant used to treat ADHD in children and adults, and binge eating ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Strattera
Strattera (atomoxetine) is used to treat attention deficit hyperactivity disorder. Learn about side ...
Concerta
Concerta is used to treat attention deficit disorder (ADD) and attention deficit hyperactivity ...
Ritalin
Ritalin (methylphenidate) is used to treat attention deficit disorder (ADD) and narcolepsy ...
Focalin
Focalin (dexmethylphenidate) is used to treat attention deficit hyperactivity disorder (ADHD) ...
More about Intuniv (guanfacine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (166)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: antiadrenergic agents, centrally acting
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.